Histopathology
组织病理学
基本信息
- 批准号:7891957
- 负责人:
- 金额:$ 24.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-08 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesComputer softwareControlled StudyCost SavingsDocumentationExperimental DesignsFrozen SectionsHistopathologyImage AnalysisManuscriptsMethodsMicroscopicParaffin EmbeddingPathologyPhotographyPreparationProcessQuality ControlReagentResearch PersonnelResourcesRetrievalSlideStaining methodStainsTissue StainsTissuesdigitalquality assuranceresearch studytissue processing
项目摘要
The Histopathology Core will provide integral support for all 3 projects. This core will centralize the
pathology resources for all of the projects of the PPG. This will result in cost savings, increased quality
control and maximal comparability between the results of the projects.
Key funcfions of the Core include: 1) expert advise in immunohistological aspects of experimental design to
optimize results; 2) uniform tissue processing; 3) tissue secfioning (frozen sections and paraffin-embedded
sections); 4) histochemical and immunohistochemical staining of tissue secfions; 5) pathological
interpretation of fissue sections; 6) documentafion of the pathology by high quality digital microscopic
photography; 7) preparation of figures for manuscripts; 8) storage and retrieval of stained slides for each of
the projects.
In addifion, this Core will be responsible for ordering, quality assurance and control studies of all anfibodies
and reagents for use in the pathology methods. New reagents will be developed and evealuated as
requested by investigators in the 3 projects.
历史学核心将为所有3个项目提供整体支持。这个核心将集中
PPG所有项目的病理学资源。这将节省成本,提高质量
项目结果之间的控制和最大可比性。
核心的主要功能包括:1)实验设计免疫组织学方面的专家建议,
优化结果; 2)均匀的组织处理; 3)组织切片(冷冻切片和石蜡包埋
切片); 4)组织切片的组织化学和免疫组织化学染色; 5)病理切片
裂隙切片的解释; 6)通过高质量的数字显微镜记录病理学
摄影; 7)为手稿准备数字; 8)存储和检索染色的幻灯片,
项目。
此外,该核心将负责所有抗体的订购、质量保证和控制研究
和用于病理学方法的试剂。新试剂将被开发和评估,
三个项目的调查人员提出的要求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William M Baldwin其他文献
MODULATION OF THE IMMUNE RESPONSE TO HPA-1A by CTLA4-Ig. † 896
- DOI:
10.1203/00006450-199604001-00918 - 发表时间:
1996-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Emily A Barron-Casella;William M Baldwin;Thomas S Kickler;James F Casella - 通讯作者:
James F Casella
William M Baldwin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William M Baldwin', 18)}}的其他基金
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10490858 - 财政年份:2021
- 资助金额:
$ 24.72万 - 项目类别:
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10337999 - 财政年份:2021
- 资助金额:
$ 24.72万 - 项目类别:
Complement regulates macrophage and platelet function in kidney transplants
补体调节肾移植中的巨噬细胞和血小板功能
- 批准号:
10681424 - 财政年份:2021
- 资助金额:
$ 24.72万 - 项目类别:
Platelets and complement in antibody-mediated rejection
抗体介导的排斥反应中的血小板和补体
- 批准号:
9086203 - 财政年份:2016
- 资助金额:
$ 24.72万 - 项目类别:
Platelets and complement in antibody-mediated rejection
抗体介导的排斥反应中的血小板和补体
- 批准号:
9283289 - 财政年份:2010
- 资助金额:
$ 24.72万 - 项目类别:
Complement and Platelets in Antibody-Medicated Rejection
抗体排斥反应中的补体和血小板
- 批准号:
7891951 - 财政年份:2010
- 资助金额:
$ 24.72万 - 项目类别:
Complement and Antibody in the Pathogenesis of AGA
AGA发病机制中的补体和抗体
- 批准号:
6739494 - 财政年份:2003
- 资助金额:
$ 24.72万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.72万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.72万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.72万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.72万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 24.72万 - 项目类别: